Cargando…
Monoclonal Antibody Therapy in Kidney Transplant Recipients With Delta and Omicron Variants of SARS-CoV-2: A Single-Center Case Series
RATIONALE & OBJECTIVE: Neutralizing monoclonal antibody treatments have shown promising preliminary results in kidney transplant recipients infected with severe acute respiratory syndrome coronavirus 2. However, their efficacy in kidney transplant recipients infected with the Omicron variant has...
Autores principales: | Fernandes, Guillaume, Devresse, Arnaud, Scohy, Anais, De Greef, Julien, Yombi, Jean Cyr, Belkhir, Leila, Darius, Tom, Mourad, Michel, Buemi, Antoine, Kabamba, Benoit, Goffin, Eric, Kanaan, Nada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9042411/ https://www.ncbi.nlm.nih.gov/pubmed/35493029 http://dx.doi.org/10.1016/j.xkme.2022.100470 |
Ejemplares similares
-
In Reply to ‘Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations’
por: Fernandes, Guillaume, et al.
Publicado: (2022) -
Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy
por: De Greef, Julien, et al.
Publicado: (2021) -
COVID-19 Infection in Kidney Transplant Recipients: A Single-Center Case Series of 22 Cases From Belgium
por: Devresse, Arnaud, et al.
Publicado: (2020) -
High response rate to BNT162b2 mRNA COVID-19 vaccine among self-care dialysis patients
por: Georgery, Hélène, et al.
Publicado: (2021) -
Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients
por: Devresse, Arnaud, et al.
Publicado: (2022)